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ABSTRACT
Two commercial feedlot experiments 
were conducted to determine the effects 
of feeding melengestrol acetate (MGA) 
or MGA plus ractopamine (MGA+OPT) 
on the performance and carcass charac-
teristics of finishing heifers. In Nebraska 
(Exp. 1), 1,807 heifers (337.3 ± 20.0 
kg) and in Texas (Exp. 2), 1,964 heif-
ers (331.5 ± 6.1 kg) were fed 0.4 mg of 
MGA daily. For heifers fed MGA+OPT, 
200 mg of ractopamine was fed daily the 
last 29 (Exp. 2) or 36 d (Exp. 1). Live 
and carcass-adjusted performance data 
were collected. On a carcass-adjusted 
basis, G:F for the entire feeding period 
was improved (P < 0.01) by 1.7 and 
3.7% in Exp. 1 and 2, respectively, for 
heifers fed MGA+OPT compared with 
MGA. For the last 29 to 36 d, G:F was 
increased (P < 0.02) by 8.1% (Exp. 1) or 
27.2% (Exp. 2) on a carcass-adjusted ba-
sis for heifers fed MGA+OPT compared 
with MGA. Fat thickness, USDA YG, 
marbling score, LM area, and percent-
age USDA Choice were not different (P 
> 0.47) between treatments in Exp. 1. 
Carcasses from heifers fed MGA+OPT 
had decreased marbling scores (P = 0.01) 
and greater LM area (P = 0.01) than 
carcasses from heifers fed MGA in Exp. 
2. In Exp. 1, in which G:F was improved 
by 8.1%, no effect on QG was observed. 
In Exp. 2, in which G:F was improved 
by 27.2%, QG decreased. Based on these 
results, feeding MGA+OPT increased 
ADG and improved G:F, with variable 
effects on carcass characteristics.
Key words:  feedlot cattle, heifer, 
melengestrol acetate, Optaflexx, rac-
topamine
INTRODUCTION
Melengestrol acetate (Pfizer Ani-
mal Health, New York City, NY) is 
an easily administered, orally active 
progestogen that has been shown to 
increase BW gain and improve feed 
efficiency when compared with heif-
ers that did not receive melengestrol 
acetate during the finishing period 
(Bloss et al., 1966; Lauderdale, 1983; 
Kreikemeier and Mader, 2004). Feed-
ing melengestrol acetate inhibits 
estrus and ovulation and is a prod-
uct commonly fed daily to finishing 
heifers at an inclusion level of 0.25 
to 0.50 mg/heifer. Carcass weights 
are the ultimate weight measure 
for determining the final value of 
a beef animal (Owens et al., 1993). 
β-Adrenergic agonists have been 
shown to cause changes in growth 
with increased accretion of skeletal 
muscle and decreased accretion of fat 
(Mersmann, 1998). Optaflexx (Elanco 
Animal Health, Greenfield, IN), the 
trade name for ractopamine-HCl, is a 
β-1 adrenergic agonist. When Opta-
flexx was fed to heifers the last 28 to 
42 d of the finishing period, heifers 
had increased weight gain on both a 
carcass-adjusted and BW basis, im-
proved feed efficiency, and no change 
in marbling when fed at a rate of 
10.0, 20.0, or 30.0 g/ton (Schroeder 
et al., 2003b). The increased BW and 
carcass weight were 7.2 and 2.9 kg, 
respectively, for heifers fed 200 mg/
heifer daily. The BW response to 
feeding Optaflexx to heifers is less 
than the response in steers (Schroeder 
et al., 2003a,b; Laudert et al., 2004). 
These previous studies were complet-
ed before MGA was cleared to be fed 
with Optaflexx; therefore, diets did 
not include melengestrol acetate, nor 
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did heifers receive implants containing 
trenbelone acetate. The objective of 
these experiments was to determine 
the effect of feeding Optaflexx in 
combination with melengestrol acetate 




The experiment was conducted 
at a commercial feedlot in central 
Nebraska between August 2004 and 
March 2005 using 1,807 British × 
Continental heifers (337.3 kg ± 20.0) 
fed in 20 pens (10 pens/treatment). 
After arrival, heifers were individually 
weighed, processed, and blocked by 
date received and site of procurement. 
Therefore, within each replication, 
cattle were received on the same day 
and from the same point of origin in 
a balanced fashion. During initial pro-
cessing, heifers were vaccinated for vi-
ral diseases (BoviShield Gold 4, Pfizer 
Animal Health), treated for internal 
and external parasites (Dectomax 
Injectable, Pfizer Animal Health), 
and implanted with Ralgro (Shering-
Plough Animal Health, Union, NJ). 
Heifers were determined to be bred, 
open, or freemartins by rectal palpa-
tion. Freemartins and heifers more 
than 100 d pregnant were removed 
from the trial. Heifers less than 100 
d pregnant were given a single 5-mL 
injection of Lutalyse (Pfizer Animal 
Health). Heifers diagnosed as open 
were not injected with Lutalyse. 
Therefore, if heifers were very early in 
pregnancy and unable to be identified 
as pregnant via rectal palpation, those 
heifers remained on trial. Heifers 
from separate locations were assigned 
randomly using processing order and 
by sorting every other heifer through 
the chute to 1 of 2 treatments. Heifers 
were then assigned randomly to their 
home pen (10 replications/treatment) 
with an average of 90 heifers/pen 
(range 60 to 145 heifers/pen). Treat-
ments were 1) heifers fed melengestrol 
acetate for the entire finishing period 
(MGA), and 2) heifers fed melenge-
strol acetate for the entire finishing 
period and Optaflexx the last 31 to 
38 d (MGA+OPT). Within each 
replication, heifers were monitored the 
same number of days during Opta-
flexx feeding in a balanced manner. 
Once initially processed, heifers were 
adapted to high-grain finishing diets; 
however, melengestrol acetate was 
not included during grain adaptation. 
The finishing diet was formulated to 
provide 0.4 mg/heifer of melengestrol 
acetate, 330 mg/heifer of Rumensin 
(Elanco Animal Health), and 90 
mg/heifer of Tylan (Elanco Animal 
Health) daily. During the last 31 to 38 
d of finishing (average of 35.5 across 
all 10 replications), Optaflexx was 
included in the diet to achieve a daily 
intake of 200 mg/heifer for heifers fed 
the MGA+OPT treatment.
Heifers were reimplanted with 
Synovex Plus (Fort Dodge Animal 
Health, Overland Park, KS) an aver-
age of 80 d preslaughter (range 73 to 
87 d), with animals implanted on the 
same day within arrival block. The 
final diet contained 38% dry-rolled 
corn, 29.5% steam-flaked corn, 18% 
wet distillers grains plus solubles, 6% 
alfalfa hay, 2% sorghum hay, 1.5% 
fat, and 5% supplement in the control 
diet (DM basis). The MGA+OPT 
supplement was delivered in a pelleted 
form fed at 4% of the dietary DM to 
replace dry-rolled corn. The Optaflexx 
supplement consisted of finely ground 
corn and wheat middlings. Diet 
samples were taken once a month and 
analyzed at a commercial laboratory. 
The finishing diet contained 14.9% 
CP, 0.72% Ca, 0.37% P, and 6.9% 
fat (DM basis). Heifers were fed an 
average of 133 d (range of 126 to 143 
d balanced within each replication). 
Feed intake was calculated by using 
the amount of feed delivered to the 
bunk of each individual pen of cattle 
and corrected for DM of ingredients.
Performance was summarized on 
both a live BW basis as well as a 
carcass-adjusted basis. For live BW 
performance, pen BW were taken for 
each pen at initial processing, reim-
plantation, the beginning of Optaflexx 
feeding, and before shipment on the 
day of slaughter. Pen weights were 
shrunk 4%. Initial pen BW were not 
shrunk because animals were pro-
cessed immediately upon arrival or 
after an overnight receiving period. 
Pen weights were used for perfor-
mance calculations on a live BW 
basis. Carcass weights were adjusted 
to a common dressing percentage of 
63.5% to calculate a carcass-adjusted 
final BW. The constant dressing 
percentage of 63.5% was used in both 
experiments to reduce the variation 
in BW measures that can occur from 
factors such as gut fill (MacDonald et 
al., 2007). Carcass-adjusted final BW 
was used to determine ADG and G:F 
on a carcass-adjusted basis.
Both pens within a block (replica-
tion) were harvested under similar 
conditions on the same day at the 
same plant. Hot carcass weights 
(HCW) and liver abscesses were 
recorded on the day of slaughter. 
Carcass fat thickness, USDA called 
marbling score, KPH, LM area, and 
USDA YG were recorded after a 
24- to 36-h chill. Yield grade was 
calculated as 2.5 + (6.35 × fat thick-
ness, cm) + (0.0017 × HCW, kg) + 
(0.2 × KPH, %) − (2.06 × LM area, 
cm2), from Boggs and Merkel (1993). 
Empty body fat was calculated as 
17.76207 + (4.68142 × rib fat thick-
ness, cm) + (0.01945 × HCW, kg) + 
(0.81855× marbling/100) − (0.06754 
× LM area, cm2), from (Guiroy et al., 
2002).
Experiment 2
This experiment was conducted at 
a commercial feedlot located in the 
Texas Panhandle between October 
2004 and February 2005 using 1,964 
(331.5 kg ± 6.1) British × Continen-
tal heifers fed in 20 pens (10 pens/
treatment). After arrival, heifers were 
individually weighed, processed, and 
blocked by date received and site of 
procurement. During initial process-
ing, heifers were vaccinated for viral 
diseases (BoviShield Gold 4 and For-
tress 7, Pfizer Animal Health), treat-
ed for internal and external parasites 
(Dectomax Injectable, Pfizer Animal 
Health), and given a single Revalor H 
implant (Intervet Inc., Millsboro, DE) 
at arrival. Heifers were determined to 
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be bred, open, or freemartins by rec-
tal palpation. Freemartins and heifers 
more than 100 d bred were removed 
from the trial. Heifers determined to 
be less than 100 d bred were given 
a single 5-mL injection of Lutalyse. 
Heifers diagnosed as open were not in-
jected with Lutalyse, which, similar to 
Exp. 1, allowed some heifers in early 
pregnancy to complete the trial. Heif-
ers were allocated to 1 of 2 treatments 
by gate-sorting groups of 2. Heifers 
were then assigned to 1 of 20 home 
pens (10 replications/treatment) with 
an average of 98 heifers/pen (range 
84 to 107). Treatments were identi-
cal to Exp. 1, with heifers fed either 
melengestrol acetate (MGA) for the 
entire finishing period or fed MGA 
for the entire finishing period and 
Optaflexx the last 29 d (range 28 to 
29 d; MGA+OPT). The finishing 
diet was formulated to provide 0.4 
mg/heifer of MGA, 330 mg/heifer of 
Rumensin, and 90 mg/heifer Tylan 
daily. The Optaflexx was included 
in the diet to provide 200 mg/heifer 
daily for heifers fed the MGA+OPT 
treatment. Heifers were fed a finishing 
diet containing 74.1% steam-flaked 
corn, 7.5% dried distillers grains, 
6.6% corn silage, 4.8% alfalfa hay, 
3.0% tallow, and 4.0% supplement 
(DM basis). Feed additives (MGA, 
Rumensin, and Tylan) were added to 
the diet with a micro-weigh machine 
in the feedmill (Micro Beef Technolo-
gies, Amarillo, TX). The Optaflexx 
was hand-weighed and added to the 
treatment diet using a water flush 
and was mixed on the feed truck at 
each feeding. Diets were tested once a 
month and analyzed at a commercial 
laboratory. The finishing diet con-
tained 13.6% CP, 0.56% Ca, 0.32% 
P, and 7.48% fat (DM basis). Heifers 
were fed an average of 138 d (range 
of 135 to 140 d, balanced within each 
replication).
Pen BW were taken for each pen 
at initial processing, at the begin-
ning of Optaflexx feeding, and before 
shipment on the day of slaughter. 
Pen BW were shrunk 4% except for 
initial pen BW because animals were 
processed immediately upon arrival. 
Pen BW were used for performance 
calculations on a BW basis. Carcass 
weights were adjusted to a com-
mon dressing percentage of 63.5% 
to calculate a carcass-adjusted final 
BW. Carcass-adjusted final BW was 
used to determine ADG and G:F on a 
carcass-adjusted basis.
All pens in this experiment were 
harvested on the same day at the 
same abattoir. Hot carcass weights 
and liver abscesses were recorded on 
the day of harvest. Carcass fat thick-
ness, USDA called marbling score, 
KPH, LM area, and USDA YG were 
recorded after a 24-h chill. Yield 
grade and empty body fat were calcu-
lated as defined for Exp. 1.
Statistical Analysis
Experiments 1 and 2 were analyzed 
as a randomized block design. Animal 
performance and carcass data were 
analyzed using the MIXED proce-
dure (SAS Inst. Inc., Cary, NC), with 
treatment as a fixed effect and block 
as a random effect. In this study, 
pen was used as the experimental 
unit. The USDA marbling score and 
calculated YG were analyzed using a 
chi-square analysis. Data are pre-
sented with dead animals and railers 
removed from the analysis.
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Table 1. Live performance and carcass-adjusted performance for 
finishing heifers fed melengestrol acetate or melegestrol acetate plus 
Optaflexx in Exp. 1 
Item MGA1 MGA+OPT2 SEM P-value
Live performance
 Initial BW, kg 337.1 336.2 6.3 0.77
 Reimplant BW, kg 448.6 447.2 8.6 0.88
 Start of Optaflexx BW, kg 523.2 525.5 7.5 0.73
 Final BW, kg 570.4 577.4 7.8 0.53
 Overall3
  DMI, kg/d 10.61 10.78 0.21 <0.01
  ADG, kg/d 1.75 1.81 0.05 0.41
  G:F 0.165 0.168 0.003 0.03
 Last 35.5 d4
  DMI, kg/d 10.37 10.67 0.13 0.01
  Total BW gain, kg 47.2 51.9 1.96 0.09
  ADG, kg/d 1.35 1.48 0.06 0.09
  G:F 0.128 0.137 0.004 0.07
Carcass-adjusted performance5
 Final BW, kg 573.2 580.5 7.5 <0.01
 Overall
  ADG, kg/d 1.88 1.94 0.05 <0.01
  G:F 0.177 0.180 0.001 <0.01
 Last 35.5 d
  Total BW gain, kg 50.1 55.1 2.5 0.02
  ADG, kg/d 1.41 1.56 0.07 0.01
  G:F 0.136 0.146 0.007 0.02
1MGA = treatment in which melengestrol acetate (Pfizer Animal Health, New York 
City, NY) was administered alone for the entire feeding period.
2MGA+OPT = treatment in which melengestrol acetate was administered for the 
entire feeding period and Optaflexx (Elanco Animal Health, Greenfield, IN) was 
included in the ration for the last 35.5 d of the finishing period.
3Heifer performance over the entire finishing period.
4Heifer performance during inclusion of Optaflexx in diet for the last 35.5 d before 
slaughter.
5Carcass-adjusted performance is hot carcass weight/0.635.
RESULTS AND DISCUSSION
Experiment 1
Fifteen animals (8 MGA+OPT and 
7 MGA) were removed from the study 
before slaughter. Four and 3 heifers 
were removed from the MGA+OPT 
and MGA treatments, respectively, af-
ter inclusion of Optaflexx. Data were 
not collected from 72 rail-outs in the 
plant (46 MGA and 26 MGA+OPT 
heifers). Of the 1,720 heifers har-
vested, 852 were fed MGA and 868 
were fed MGA+OPT. Fetuses were 
observed at slaughter in 82 heifers: 39 
in the MGA treatment and 43 in the 
MGA+OPT treatment. These preg-
nant heifers were included in the final 
analysis because we observed approxi-
mately the same number of heifers 
in each treatment, and there was no 
difference in performance between 
treatments with or without these heif-
ers included.
The diet containing Optaflexx was 
formulated to achieve an intake of 200 
mg/d per heifer; however, based on 
DMI changes across block (range 10.1 
to 11.8 kg/d), actual Optaflexx intake 
averaged 205.0 mg/d per heifer (range 
185.1 to 222.4 mg/d per heifer). Opta-
flexx is approved to be fed at a rate 
of 70 to 430 mg/d per heifer. Animals 
consumed an average of 0.371 mg/kg 
Optaflexx (range 0.346 to 0.383 mg/
kg) when calculated on a kilogram of 
BW basis.
Live and carcass-adjusted perfor-
mance results are presented in Table 
1 for Exp. 1. Final live BW was not 
different (P = 0.53), but final live 
BW was numerically increased by 7.0 
kg or 1.2% in heifers fed MGA+OPT. 
Dry matter intake was increased by 
0.17 kg/d (P < 0.01) for heifers fed 
MGA+OPT compared with heif-
ers fed MGA alone over the entire 
feeding period. Feed efficiency was 
improved 1.8% (P = 0.03) for heifers 
fed MGA+OPT compared with heif-
ers fed MGA, even though ADG was 
not affected (P = 0.41) when compar-
ing treatments over the entire 133-d 
finishing period on a live BW basis.
When comparing treatments dur-
ing the last 35.5 d (the time heifers 
were fed Optaflexx), heifers receiving 
MGA+OPT were numerically heavier 
(525.5 vs. 523.2 kg) at the begin-
ning of the period. Given this 2.3-kg 
advantage in initial BW for heifers fed 
MGA+OPT, the BW gain increase 
for heifers assigned to MGA+OPT 
was 4.7 kg, an improvement in BW 
gain of 10.2% (P = 0.09) compared 
with heifers fed MGA. Dry matter 
intake was increased (P = 0.01) by 
0.30 kg/heifer. Feeding MGA+OPT 
increased ADG (live basis) by 0.13 
kg/d (P = 0.09), which led to a 7.0% 
improvement (P = 0.07) in feed effi-
ciency compared with heifers receiv-
ing MGA.
On a carcass-adjusted basis 
(HCW/0.635), final BW was in-
creased (P = 0.01) by 7.3 kg or 1.3% 
for heifers receiving MGA+OPT com-
pared with heifers fed MGA. When 
ADG was calculated from carcass 
weight, heifer ADG was increased (P 
< 0.01) by 0.06 kg/heifer, with an im-
provement (P < 0.01) in feed efficien-
cy of 1.7% for heifers over the entire 
feeding period. Despite the relatively 
small improvement when expressed 
over the entire feeding period, ADG 
and G:F of heifers fed MGA+OPT 
compared with heifers fed MGA on 
a carcass-adjusted basis were sig-
nificantly different. When looking at 
only the last 35.5 d of performance, 
MGA+OPT heifers gained 0.15 kg/d 
more (P = 0.01), and G:F improved 
by 8.1% (P = 0.02) compared with 
heifers receiving MGA.
Carcasses of heifers in the 
MGA+OPT treatment groups 
(Table 2) did not differ in USDA YG, 
marbling score, percentage of USDA 
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Table 2. Carcass characteristics for finishing heifers fed melengestrol 
acetate or melengestrol acetate plus Optaflexx in Exp. 1 
Item MGA1 MGA+OPT2 SEM P-value
Hot carcass weight, kg 364.7 368.0 1.7 0.02
Fat thickness, cm 1.43 1.42 0.04 0.62
YG3 2.74 2.76 0.10 0.72
 YG 1, % 19.1 17.1 — —
 YG 2, % 44.7 45.7 — —
 YG 3, % 29.9 31.1 — —
 YG 4, % 5.5 5.5 — —
 YG 5, % 0.7 0.6 — —
Marbling4 553.6 551.7 6.1 0.72
 Prime, % 1.2 1.2 — —
 Choice +, % 4.9 6.5 — —
 Choice0, % 20.0 17.4 — —
 Choice−, % 45.8 46.4 — —
 Select, % 27.1 27.5 — —
 Standard, % 0.9 1.0 — —
LM area, cm2 92.95 92.82 1.39 0.88
KPH, % 1.96 1.95 0.01 0.24
Dressing percentage, % 63.82 63.85 0.22 0.87
Empty body fat,5 % 29.75 29.74 0.25 0.96
1MGA = treatment in which melengestrol acetate (Pfizer Animal Health, New York 
City, NY) was administered alone for the entire feeding period.
2MGA+OPT = treatment in which melengestrol acetate was administered for the 
entire feeding period and Optaflexx (Elanco Animal Health, Greenfield, IN) was 
included in the ration for the last 35.5 d of the finishing period.
3YG = 2.5 + (6.35 × fat thickness, cm) + (0.0017 × hot carcass weight, kg) + (0.2 × 
KPH, %) − (2.06 × LM area); from Boggs and Merkel (1993).
4Marbling = 400 = Slight0, 500 = Small0, and so on.
5Empty body fat = 17.76207 + (4.68142 × rib fat thickness, cm) + (0.01945 × hot 
carcass weight, kg) + (0.81855 × marbling/100) − (0.06754 × LM area, cm2); from 
Guiroy et al. (2002).
choice and select based on chi-square 
analysis, fat thickness, LM area, 
KPH, empty body fat, cutability, and 
dressing percentage when compared 
with heifers fed MGA. However, 
heifers fed MGA+OPT had 3.3 kg 
heavier (0.9%) HCW (P < 0.01).
Experiment 2
Forty-nine heifers (22 MGA+OPT 
and 27 MGA) were removed from 
the study before slaughter. One and 
2 heifers were removed from the 
MGA and the MGA+OPT treat-
ment, respectively, after inclusion 
of Optaflexx. Of the 1,915 heifers 
harvested, 957 were fed MGA and 958 
were fed MGA+OPT. Fetuses were 
observed in 56 heifers at slaughter: 
22 in the MGA treatment and 34 in 
the MGA+OPT group. These preg-
nant heifers were included in the final 
analysis for the same reasons as in 
Exp. 1.
In this study, the MGA+OPT diet 
was formulated to achieve 200 mg/
heifer daily. Based on the method 
(micro-weigh machine) in which Opta-
flexx was delivered to the bunk, DMI 
differences (range 8.3 to 9.4 kg) across 
block had no effect on actual Opta-
flexx intake. Therefore, daily intake 
of Optaflexx averaged 200 mg/heifer. 
Animals consumed an average of 
0.384 mg/kg Optaflexx (range 0.366 
to 0.396 mg/kg) when calculated on a 
per kilogram of BW basis.
Heifer live and carcass-adjusted 
performance results are presented 
in Table 3. Final live BW was not 
different (P = 0.35) between treat-
ments, although heifers receiving 
MGA+OPT were 4.1 kg (0.8%) 
heavier than animals receiving MGA. 
Total BW gain during Optaflexx feed-
ing was greater (P < 0.01) for heifers 
receiving MGA+OPT compared with 
heifers receiving MGA. The DMI was 
not affected by feeding Optaflexx (P 
= 0.95) over the entire feeding period. 
Average daily gain was not statisti-
cally different (P = 0.10), but showed 
a numerical increase of 0.05 kg/d for 
heifers fed MGA+OPT compared 
with heifers fed MGA. Feed effi-
ciency was improved by 3.7% when 
Optaflexx was included in the diet 
of heifers receiving MGA (P < 0.01), 
even though DMI and ADG were only 
slightly affected over the entire 138-d 
feeding period.
Over the last 29 d on feed (the time 
heifers were receiving Optaflexx), 
DMI was not influenced (P = 0.94) 
by treatment. Final BW minus BW 
at the beginning of Optaflexx feeding 
exhibited a 7.7-kg (P < 0.01) im-
provement in BW gain in MGA+OPT 
compared with heifers fed MGA. 
Feeding MGA+OPT increased ADG 
0.26 kg/d (25.5%) when compared 
with heifers receiving MGA (P < 
0.01). Increased ADG, without a 
change in DMI, caused heifers receiv-
ing MGA+OPT to be 26.5% more 
efficient (P < 0.01) compared with 
heifers receiving MGA.
Carcass-adjusted live performance 
(HCW/0.635) over the entire feed-
ing period indicated heifers receiving 
MGA+OPT had a 5.1 kg heavier ad-
justed final BW (P = 0.19). Because 
of the difference in heifer BW at the 
initiation of Optaflexx, BW gained 
over the last 29-d period was 37.9 kg 
for MGA+OPT compared with 29.2 
kg for heifers receiving MGA, an 8.7-
kg difference (P < 0.01). Heifers re-
ceiving MGA+OPT gained 0.05 kg/d 
(3.4%) more (P = 0.04) when com-
pared with heifers receiving MGA. 
Feed efficiency was also improved by 
3.7% (P < 0.01) for heifers receiv-
ing MGA+OPT. During the last 29 
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Table 3. Live performance and carcass-adjusted performance for 
finishing heifers fed melengestrol acetate or melegestrol acetate plus 
Optaflexx in Exp. 2 
Item MGA1 MGA+OPT2 SEM P-value
Live performance
 Initial BW, kg 331.9 329.7 2.0 0.09
 Start of Optaflexx BW, kg 505.4 501.8 3.6 0.43
 Final BW, kg 534.9 539.0 3.5 0.35
 Overall3
  DMI, kg/d 8.98 8.97 0.12 0.95
  ADG, kg/d 1.47 1.52 0.02 0.10
  G:F 0.163 0.169 0.002 <0.01
 Last 29 d4
  DMI, kg/d 8.82 8.81 0.10 0.94
  Total BW gain, kg 29.5 37.2 1.4 <0.01
  ADG, kg/d 1.02 1.28 0.05 <0.01
  G:F 0.113 0.143 0.005 <0.01
Carcass-adjusted performance5
 Final BW, kg 534.6 539.7 2.2 0.19
 Overall
  ADG, kg/d 1.47 1.52 0.02 0.04
  G:F 0.163 0.169 0.002 <0.01
 Last 29 d
  Total BW gain, kg 29.2 37.9 1.5 <0.01
  ADG, kg/d 0.99 1.29 0.05 <0.01
  G:F 0.114 0.144 0.005 <0.01
1MGA = treatment in which melengestrol acetate (Pfizer Animal Health, New York 
City, NY) was administered alone for the entire feeding period.
2MGA+OPT = treatment in which melengestrol acetate was administered for the 
entire feeding period and Optaflexx (Elanco Animal Health, Greenfield, IN) was 
included in the ration for the last 29 d of the finishing period.
3Heifer performance over the entire finishing period.
4Heifer performance during inclusion of Optaflexx in diet for the last 29 d before 
slaughter.
5Carcass-adjusted performance is hot carcass weight/0.635.
d of the feeding period, heifers fed 
MGA+OPT gained 0.30 kg/d more 
(P < 0.01), a 30.3% improvement, 
and exhibited an improvement in G:F 
of 27.2% (P < 0.01) over MGA heif-
ers.
Carcasses of heifers fed MGA+OPT 
were 3.2 kg heavier than those from 
heifers fed MGA (Table 4). How-
ever, because of the difference in 
BW at the beginning of Optaflexx 
feeding, initial BW at the beginning 
of Optaflexx feeding (BW × 0.635 
subtracted from the HCW) was used 
to determine the amount of carcass 
weight gained in the last 29 d of the 
feeding period. With this approach, 
heifers receiving MGA+OPT gained 
24.1 kg of carcass weight compared 
with 18.6 kg for heifers receiving 
MGA. Assuming that differences 
in live BW are real, heifers receiv-
ing Optaflexx actually gained 5.5 kg 
more (instead of 3.4 kg) than heifers 
receiving MGA. When other carcass 
characteristics were compared, no 
significant differences were observed 
between MGA and MGA+OPT for 
fat thickness, KPH fat, dressing per-
centage, empty body fat, or cutability. 
Carcasses of heifers fed MGA+OPT 
had reduced marbling scores (P = 
0.01) and 2.37 cm2 greater LM area 
(P = 0.01) and tended to exhibit 
reduced YG (2.48 vs. 2.59; P = 0.11) 
compared with carcasses from heif-
ers fed MGA. Carcasses from heifers 
receiving MGA+OPT graded 59.9% 
Low Choice or better compared with 
71.4% for heifers receiving MGA (P 
= 0.05).
Previous research by Laudert et al. 
(2004) and Schroeder et al. (2003a) 
showed steers receiving Optaflexx 
gained, respectively, 6.7 and 7.2 kg 
of BW more compared with con-
trol steers. Carcass weight was also 
increased by 5.6 and 6.4 kg compared 
with control steers. Similar responses 
were observed by Abney et al. (2007), 
in which final BW, ADG, and G:F in-
creased linearly as the Optaflexx dose 
increased from 0 to 200 mg of Opta-
flexx daily. Final BW increased by 
9.4 kg and carcass weight increased 
by 6.9 kg for steers fed 200 mg of 
Optaflexx for either 28, 35, or 42 d 
compared with no Optaflexx (Abney 
et al., 2007). These authors did not 
observe an interaction between length 
of feeding and dose. Winterholler et 
al. (2007) observed an 11-kg increase 
in final BW and an 8-kg increase in 
HCW for steers fed 200 mg of Opta-
flexx daily for 28 d in a commercial 
study.
However, with heifers, Schroeder et 
al. (2003b) found that those fed Opta-
flexx were 6.6 kg heavier (live BW 
basis) and had 2.9-kg heavier car-
casses compared with heifers not fed 
Optaflexx. At the time of their heifer 
research, Optaflexx was not approved 
to be fed with melengestrol acetate. 
Therefore, melengestrol acetate was 
not included in the diet and heifers 
were not implanted with trenbelone 
acetate. In the current study, live 
BW and carcass gain responses to 
Optaflexx with melengestrol acetate 
feeding were greater than previously 
observed for heifers not fed melenge-
strol acetate. Responses of the current 
study are more comparable with those 
observed in steers and in more recent 
heifer studies. Walker et al. (2006) 
individually fed 72 heifers 0 or 200 mg 
Optaflexx with melengestrol acetate 
included and observed a 6.9-kg in-
crease in HCW when averaged across 
different protein treatments (with no 
interaction observed). In their study, 
ADG and G:F were increased by ap-
proximately 25% and were significant 
when using carcass-adjusted perfor-
mance.
Quinn et al. (2008) fed approxi-
mately 300 heifers either 0 or 200 
mg of Optaflexx and observed an 
improvement of only 9.6% in G:F in 
their first experiment, with no signifi-
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Table 4. Carcass characteristics for finishing heifers fed melengestrol 
acetate or melengestrol acetate plus Optaflexx in Exp. 2 
Item MGA1 MGA+OPT2 SEM P-value
Hot carcass weight, kg 339.5 342.7 2.2 0.19
Fat thickness, cm 1.36 1.35 0.05 0.72
YG3 2.59 2.48 0.07 0.11
 YG 1, % 24.8 28.5 — —
 YG 2, % 43.5 47.6 — —
 YG 3, % 27.0 19.1 — —
 YG 4, % 4.5 4.4 — —
 YG 5, % 0.2 0.4 — —
Marbling4 534.0 519.4 7.1 0.01
 Prime, % 0.9 1.5 — —
 Choice +, % 0.8 0.5 — —
 Choice0, % 11.7 8.5 — —
 Choice−, % 58.0 49.4 — —
 Select, % 28.3 39.5 — —
 Standard, % 0.3 0.6 — —
LM area, cm2 90.24 92.61 0.72 0.01
KPH, % 1.88 1.86 0.01 0.36
Dressing percentage, % 63.47 63.58 0.09 0.39
Empty body fat,5 % 28.18 27.89 0.31 0.27
1MGA = treatment in which melengestrol acetate (Pfizer Animal Health, New York 
City, NY) was administered alone for the entire feeding period.
2MGA+OPT = treatment in which melengestrol acetate was administered for the 
entire feeding period and Optaflexx (Elanco Animal Health, Greenfield, IN) was 
included in the ration for the last 29 d of the finishing period.
3YG = 2.5 + (6.35 × fat thickness, cm) + (0.0017 × hot carcass weight, kg) + (0.2 × 
KPH, %) − (2.06 × LM area); from Boggs and Merkel (1993).
4Marbling = 400 = Slight0, 500 = Small0, etc.
5Empty body fat = 17.76207 + (4.68142 × rib fat thickness, cm) + (0.01945 × hot 
carcass weight, kg) + (0.81855 × marbling/100) − (0.06754 × LM area, cm2); from 
Guiroy et al. (2002).
cant differences in BW or HCW. In 
their second experiment, their treat-
ment design was unique in that they 
fed Optaflexx at a rate of 200 mg for 
28 or 42 d, fed Optaflexx at a rate 
of 300 mg for 28 d, or fed a treat-
ment that had increasing amounts of 
Optaflexx across 42 d (100 mg, then 
200 mg, followed by 300 mg) and 
observed that heifers fed Optaflexx 
had a 3- to 8-kg increase in HCW 
across the different Optaflexx treat-
ments (Quinn et al., 2008). Although 
the different treatments containing 
Optaflexx were not different from 
each other, the heifers fed 200 mg 
for 42 d had the numerically greatest 
increase in HCW. In our study, heifers 
fed Optaflexx for 29 d (Exp. 2) had 
a much greater response in ADG and 
G:F than heifers fed for an average of 
36 d (Exp. 1).
In previous Optaflexx studies 
(Schroeder et al., 2003a), DMI was 
not affected by treatment, and simi-
lar results were observed in Exp. 2. 
However, in Exp. 1, DMI was slightly 
greater for heifers fed MGA+OPT 
compared with heifers fed MGA. 
Many experiments have observed no 
change in DMI (Abney et al., 2007; 
Sissom et al., 2007; Winterholler et 
al., 2007).
Previous research (Schroeder et 
al., 2003b) showed heifers fed Opta-
flexx alone demonstrated a 17.5% 
improvement (P < 0.03) in ADG 
when compared with control heifers 
and a 14.0% improvement in G:F (P 
< 0.03) during a 28- to 42-d feeding 
period. In Exp. 1, ADG was improved 
by 10.6% and G:F was improved by 
8.1% when Optaflexx was fed. In 
Exp. 2, ADG increased 30.3%, with 
a 27.2% improvement in G:F for 
heifers fed MGA+OPT compared 
with heifers fed MGA. The results 
from Exp. 1 were not as great as the 
improvement shown by Schroeder et 
al. (2003b). In Exp. 2, however, heif-
ers fed MGA+OPT performed better 
than heifers fed Optaflexx with no 
melengestrol acetate (Schroeder et al., 
2003b).
When evaluating the entire feeding 
period with shrunk initial BW and 
HCW to avoid possible errors in BW 
measurement, the response to feeding 
MGA+OPT compared with MGA 
was 3.2 and 3.4% for Exp. 1 and Exp. 
2, respectively. However, G:F was 
increased by 1.7 and 3.7% by feeding 
MGA+OPT compared with MGA for 
Exp. 1 and Exp. 2, respectively. Sis-
som et al. (2007) evaluated Optaflexx 
fed at 200 mg for 28 d in 2 com-
mercial experiments with all feedlot 
heifers fed melengestrol acetate. Their 
first experiment evaluated 2 implant 
regimens factorialized with Optaflexx 
(0 or 200 mg), and no interactions be-
tween implant regimen and Optaflexx 
feeding were observed. Over the 182-d 
feeding period, ADG was increased 
2.2% and G:F was increased by 3.9% 
(Sissom et al., 2007). In their second 
experiment, heifers were fed for a to-
tal of 129, 150, or 170 d and no inter-
action between Optaflexx treatment 
and days on feed were observed. The 
only significant response was observed 
for G:F, which increased 2.4% because 
of Optaflexx (Sissom et al., 2007).
Schroeder et al. (2003b) found that 
feeding Optaflexx had no effect on 
fat thickness, KPH, LM area, YG, or 
marbling. No carcass quality changes 
were observed between heifers fed 
MGA or MGA+OPT in Exp. 1. 
However, there was an increase in 
LM area and a significant decrease 
in marbling score in Exp. 2. When 
comparing USDA QG, Exp. 1 showed 
no difference between treatments for 
percent Choice carcasses. In Exp. 2, 
there was a difference in carcass QG, 
with less USDA Choice carcasses for 
heifers fed MGA+OPT vs. MGA 
(59.9 vs. 71.4%, respectively).
Heifers were implanted differently 
between Exp. 1 and Exp. 2. Heifers 
in Exp. 1 received a mild estrogen 
implant upon arrival and were reim-
planted with a strong combination 
implant. Heifers in Exp. 2 were im-
planted once at arrival with a moder-
ate combination implant. Implants 
have been shown to decrease the QG 
of cattle (Crouse et al., 1987; Simms 
et al., 1988) when comparisons are 
made with similar days on feed and 
not at the same empty body fat or 
composition. When implant programs 
were compared at equal empty body 
fat, carcass quality appeared to be 
unaffected (Guiroy et al., 2002). 
There was no difference between 
marbling scores when comparing 
implant programs that used a mild 
combination or a strong combination 
implant program (Morgan, 1997). In 
Exp. 1, with an aggressive implant 
program, there was no difference in 
carcass quality caused by Optaflexx 
feeding; however, in Exp. 2, with a 
less aggressive implant in heifers fed 
MGA+OPT, carcass quality was 
decreased compared with feeding 
MGA. These data suggest that an 
aggressive implant program can be 
used in heifers receiving MGA+OPT 
without affecting carcass quality. This 
conclusion is further supported by 
Sissom et al. (2007), who did not ob-
serve an interaction between implant 
treatments and Optaflexx feeding. 
Clearly, previous research with steers 
representing different genotypes and 
implant programs suggests that the 
influence of Optaflexx on carcass 
quality characteristics is consistent in 
terms of carcass quality (Schroeder et 
al., 2003a; Gruber et al., 2007).
In Exp. 2, heifers receiving 
MGA+OPT had an empty body fat 
percentage that was 0.29 percentage 
units less than heifers receiving MGA 
(P = 0.27). Although not significant, 
this difference in empty body fat may 
suggest that heifers were at different 
body compositions between these 2 
treatments before Optaflexx feeding, 
or that body composition was influ-
enced by Optaflexx feeding. Because 
no effect of feeding Optaflexx was 
observed on body composition in 
Exp. 1, and in previous heifer stud-
ies (Schroeder et al., 2003b), body 
composition may have been different 
between heifers on each treatment 
before initiation of Optaflexx feeding. 
It is unclear what other factors may 
have led to different carcass qual-
ity responses between treatments in 
Exp. 1 and 2. Previous research with 
feeding Optaflexx to heifers suggests 
no effect on marbling (Walker et al., 
2006; Sissom et al., 2007; Quinn et 
al., 2008); however, these studies have 
observed variable impacts of feeding 
39Use of melengestrol acetate and Optaflexx in feedlot heifers
Optaflexx to heifers in terms of LM 
area and fat depth.
Previous research suggests that 
providing Optaflexx to heifers at inclu-
sion amounts greater than 200 mg can 
lead to decreases in marbling score 
(Schroeder et al., 2003b), whereas 
ADG and G:F are improved. However, 
in previous studies, Optaflexx fed at 
rates of 200 mg or less per day did not 
negatively affect carcass quality. Heif-
ers consumed 205.0 and 200.0 mg/heif-
er daily in Exp.1 and 2, respectively, 
suggesting that carcass quality should 
not be negatively affected. Optaflexx 
intakes, expressed as milligrams of 
intake per kilogram of BW, were 0.371 
and 0.384, respectively, for Exp. 1 and 
2. Although this difference is small be-
tween Exp. 1 and 2, Optaflexx intake 
(on a mg/kg BW basis) may partially 
explain the difference in ADG and G:F 
responses between experiments.
Based on results from these 2 ex-
periments and previous research with 
heifers, the response to MGA+OPT 
consistently improved ADG and G:F. 
The most difficult response to quantify 
consistently across these experiments 
appeared to be the absolute BW 
response to feeding Optaflexx to heif-
ers. This was likely due to difficulty in 
obtaining accurate BW measurements, 
especially late in the feeding period. 
However, based on these 2 experi-
ments and recent research with heifers 
fed Optaflexx, the observed increase 
in HCW attributable to Optaflexx 
suggests the BW response was greater 
for Optaflexx when fed in combination 
with melengestrol acetate than in early 
studies in which melengestrol acetate 
was not fed with Optaflexx. Interest-
ingly, when the BW response was less 
within these 2 experiments, no quality 
differences were observed (i.e., in Exp. 
1). When the BW response was large 
in Exp. 2, then marbling score was 
slightly reduced; therefore, the effects 
on degree of marbling may be influ-
enced by the magnitude of the BW 
response.
IMPLICATIONS
These data suggest that feeding 
Optaflexx at 200 mg/heifer during the 
last 29 to 38 d of the finishing period 
in combination with melengestrol 
acetate to feedlot heifers will increase 
final BW, improve ADG, and improve 
feed efficiency compared with feeding 
melengestrol acetate alone. Feed-
ing Optaflexx in combination with 
melengestrol acetate had variable 
impacts on carcass quality. Optaflexx 
appears to have no effect on fat thick-
ness, KPH, or empty body fat com-
pared with heifers fed melengestrol 
acetate alone.
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